A case report of urticaria as a rare side effect of favipiravir in a patient with COVID-19
COVID-19 pandemic has been caused by severe acute respiratory syndrome coronavirus 2 which has caused worldwide health concerns. A 48-year-old female suffering from COVID-19 was started on favipiravir (FPV) along with other drugs. Within 12 h of initiation of FPV, the patient developed urticaria all...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Allergy Asthma and Immunology |
Subjects: | |
Online Access: | http://www.ijaai.in/article.asp?issn=0972-6691;year=2021;volume=35;issue=2;spage=103;epage=105;aulast=Kumar |